MedPath

Verification of the effect of sacubitril valsartan sodium hydrate on the residual renal function of peritoneal dialysis patients

Not Applicable
Recruiting
Conditions
End-stage renal failure
Registration Number
JPRN-UMIN000048227
Lead Sponsor
International University of Health and Welfare
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
All
Target Recruitment
45
Inclusion Criteria

Not provided

Exclusion Criteria

Those who did not consent to participate in the study.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Comparison of the rate of decrease in residual renal function in each group after 6 months of distribution to 3 groups.
Secondary Outcome Measures
NameTimeMethod
Comparison of blood pressure in each group after 6 months of distribution to 3 groups .Comparison of cardiac function (EF) by Biplane Modified Simpson method in each group after 6 months of 3 groups.Comparison of peritoneal function in each group after 6 months of distribution to 3 groups.
© Copyright 2025. All Rights Reserved by MedPath